Anthera Pharmaceuticals (ANTH) News Today → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free ANTH Stock Alerts Add Compare Share Share HeadlinesStock AnalysisChartFinancialsSEC FilingsShort InterestStock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 28, 2023 | finance.yahoo.comMACK - Merrimack Pharmaceuticals, Inc.May 16, 2023 | marketwatch.comIndustry Research Report on Cystic Fibrosis Drugs Market Share and Industrial Overview till 2030May 16, 2023 | marketwatch.comSystemic Lupus Erythematosus (SLE) Drugs Market Updates: 2023-2030 ForecastMay 5, 2023 | marketwatch.com2023-2030 Vasculitis Treatment Market Size (Growth and Outlook) includes Main Business Overview | with [124 Pages]May 4, 2023 | marketwatch.com2023-2030 Gaucher Disease Treatment Market Size (Growth and Outlook) includes Company Information | with [104 Pages]April 28, 2023 | marketwatch.comGaucher Disease Treatment Market Top Key Players by 2030April 7, 2023 | marketwatch.comGlobal Cystic Fibrosis Drugs Market Size 2023 to 2026 Size and Share Survey ReportMarch 28, 2023 | marketwatch.comCeliac Disease Drug Market Size and Forecast till 2030March 10, 2023 | marketwatch.comCystic Fibrosis Drugs Market 2023-2028 Recent Study by Trend and Growth AnalysisMarch 8, 2023 | finance.yahoo.comInfectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc.February 26, 2023 | thestreet.comTwo Drugs, Designed To Help Patients, Actually Hurt ThemJanuary 13, 2023 | marketwatch.comGaucher Disease Treatment Market Provides an In-Depth Insight of Trends and Landscape Outlook 2023-2028January 7, 2023 | marketwatch.comCeliac Drugs Market Trends, Business Overview, Industry Growth, and Forecast 2023 To 2028December 17, 2022 | marketwatch.comGaucher Disease Treatment Market Research report forecast 2023 To 2028, Latest Industry News, Top Company Analysis, Research MethodologyOctober 12, 2022 | marketwatch.comCystic Fibrosis Drugs Market 2022 | Upcoming Trends, Recent Development, Top Manufacturers, Industry Drivers and Forecast to 2028September 1, 2022 | apnews.comThryv Therapeutics Inc. Announces the Appointment of Dr. Debra Odink to President and Dr. Shi Yin Foo to the Board of DirectorsAugust 26, 2022 | reuters.comANTH.PQ - Anthera Pharmaceuticals Inc | Stock Price & Latest News | ReutersJune 10, 2022 | benzinga.comAnthera Pharmaceuticals (OTC:ANTH), Short Interest ReportMay 10, 2022 | marketwatch.comVasculitis Treatment Market Size 2022 including Scope, Trends, Manufacturers, Growth Factors, Market Dynamics and Forecast to 2028April 21, 2022 | bizjournals.comThe Petri Dish: Two startups get new CEOs, workforce dev coalition ramps upApril 14, 2022 | finanznachrichten.deNervGen Pharma Corp.: NervGen Pharma Appoints Craig Thompson to the Board of DirectorsApril 13, 2022 | finance.yahoo.comNervGen Pharma Appoints Craig Thompson to the Board of DirectorsNovember 24, 2021 | finanznachrichten.deSanthera Pharmaceuticals Holding AG: Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completion of the VISION-DMD StudyOctober 26, 2021 | sg.finance.yahoo.comAnthera Pharmaceuticals, Inc. (ANTH)October 4, 2021 | marketwatch.comEPI Market 2021 : Global Industry Analysis, Trends, Market Size and Forecasts Up to 2025 with Dominant Sectors and Countries DataAugust 12, 2021 | marketwatch.comHemoglobinopathies Market Revenue Growth, New Launches, Regional Share Analysis & Forecast Till 2027August 2, 2021 | nasdaq.comAnthera Pharmaceuticals Inc (ANTH)August 2, 2021 | barrons.comAnthera Pharmaceuticals Inc.July 23, 2021 | marketwatch.comSystemic Lupus Erythematous Sle Drugs Market Size 2021 to 2026 Segmentation at Region Level Including Market Revenue, Share and Price Analysis Get Anthera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Charles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. ANTH Media Mentions By Week ANTH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANTH News Sentiment▼0.000.55▲Average Medical News Sentiment ANTH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANTH Articles This Week▼00▲ANTH Articles Average Week Get Anthera Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BAYRY News Today CAPS News Today CNTX News Today IMUC News Today GNMSF News Today GRFS News Today HYPMY News Today ISCO News Today LVTX News Today MYNZ News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ANTH) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anthera Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.